SynthesisInternational journal of nanomedicine2025
New Strategies in Comprehensive Melanoma Treatment: Applications, Potential, and Challenges of Hydrogels.
Synthesis in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanisms and therapeutic design of stimuli-responsive vesicular nanocarriers for melanoma.International journal of pharmaceutics: X · 2026Review
- Endothelial cell heterogeneity drives angiogenesis in endometriosis: mechanisms and emerging organoid-based models.Apoptosis : an international journal on programmed cell death · 2026Review
- Circular RNA rising star: new findings of circPRMT5 in cancer.Molecular biology reports · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the rising incidence and mortality rates of melanoma, the limitations of traditional treatment methods have become increasingly evident. These approaches often lack precision, cause systemic toxicity, or fail to prevent recurrence, falling short of current treatment needs such as efficacy, safety, and long-term tumor control. Melanoma progression involves complex biological features such as uncontrolled proliferation, immune evasion, and metastasis, which are crucial for understanding clinical behavior and guiding treatment design. Hydrogels have recently emerged as a promising platform in the field of cancer therapy due to their tunable physicochemical properties, biocompatibility, and capacity for localized, controlled drug delivery. To provide a comprehensive and methodologically sound overview, we systematically searched the PubMed database using the keywords "hydrogel" and "melanoma" for studies published up to December 2024. Studies were screened based on relevance, originality, and experimental support. This review focuses on hydrogel-based strategies for melanoma treatment, highlighting: (1) recent advances in hydrogel design and functionality; (2) their integration with therapeutic approaches such as immunotherapy, chemotherapy, and photothermal therapy; and (3) their potential in postoperative wound management. In addition, we discuss the role of material selection in hydrogel performance and explore how the combination of distinct therapeutic approaches within hydrogel systems can synergistically improve treatment outcomes. Finally, we address the current challenges facing clinical translation, including safety, efficacy, and regulatory hurdles, while outlining potential pathways to overcome these barriers. This review aims to support future research and clinical innovation by providing a structured, up-to-date overview of hydrogel applications in melanoma therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.